NeuroOne Medical Technologies Corporation Common Stock
0.89
USD
Patrocinado
-0.09
-9.03%
07 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
0.90
+0.01
+0.90%
Relatórios de Lucros NMTC
Rácio de surpresa positiva
NMTC separação 12 de 15 últimas estimativas.
80%
Próximo Relatório
Data do Próximo Relatório
10 de fev. de 2026
Estimate forQ1 26(Revenue/ EPS)
$2.68M
/
-$0.04
Mudanças implicadas deQ4 25(Revenue/ EPS)
-2.20%
/
--
Mudanças implicadas deQ1 25(Revenue/ EPS)
-18.03%
/
-166.67%
NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue
On 15 de dez. de 2025, NMTC reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.03 USD, resulting in a --% surprise. Revenue reached 2.74 milhão, compared to an expected 2.52 milhão, with a 8.79% difference. The market reacted with a +6.93% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analistas forecast an EPS of -0.04 USD, with revenue projected to reach 2.68 milhão USD, implying an -- of --% EPS, and diminuir of -2.20% in Revenue from the last quarter.
FAQ
What were NeuroOne Medical Technologies Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, NeuroOne Medical Technologies Corporation Common Stock reported EPS of --, missing estimates by --, and revenue of $2.74M, 8.79% above expectations.
How did the market react to NeuroOne Medical Technologies Corporation Common Stock's Q4 2025 earnings?
The stock price moved up 6.93%, changed from $0.66 before the earnings release to $0.71 the day after.
When is NeuroOne Medical Technologies Corporation Common Stock expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for NeuroOne Medical Technologies Corporation Common Stock's next earnings report?
Based on 4
analistas, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.04 and revenue of $2.68M for Q1 2026.